1. Home
  2. ROOT vs MDXG Comparison

ROOT vs MDXG Comparison

Compare ROOT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROOT
  • MDXG
  • Stock Information
  • Founded
  • ROOT 2015
  • MDXG 2006
  • Country
  • ROOT United States
  • MDXG United States
  • Employees
  • ROOT N/A
  • MDXG N/A
  • Industry
  • ROOT Property-Casualty Insurers
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROOT Finance
  • MDXG Health Care
  • Exchange
  • ROOT Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • ROOT 1.1B
  • MDXG 1.1B
  • IPO Year
  • ROOT 2020
  • MDXG N/A
  • Fundamental
  • Price
  • ROOT $85.31
  • MDXG $9.12
  • Analyst Decision
  • ROOT Buy
  • MDXG Strong Buy
  • Analyst Count
  • ROOT 9
  • MDXG 5
  • Target Price
  • ROOT $58.38
  • MDXG $12.00
  • AVG Volume (30 Days)
  • ROOT 323.0K
  • MDXG 674.7K
  • Earning Date
  • ROOT 02-19-2025
  • MDXG 02-26-2025
  • Dividend Yield
  • ROOT N/A
  • MDXG N/A
  • EPS Growth
  • ROOT N/A
  • MDXG N/A
  • EPS
  • ROOT N/A
  • MDXG 0.52
  • Revenue
  • ROOT $1,044,599,999.00
  • MDXG $342,804,000.00
  • Revenue This Year
  • ROOT N/A
  • MDXG $9.56
  • Revenue Next Year
  • ROOT $8.55
  • MDXG $9.19
  • P/E Ratio
  • ROOT N/A
  • MDXG $18.12
  • Revenue Growth
  • ROOT 215.11
  • MDXG 10.93
  • 52 Week Low
  • ROOT $7.22
  • MDXG $5.47
  • 52 Week High
  • ROOT $118.15
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • ROOT 59.04
  • MDXG 53.35
  • Support Level
  • ROOT $71.75
  • MDXG $8.50
  • Resistance Level
  • ROOT $89.92
  • MDXG $9.71
  • Average True Range (ATR)
  • ROOT 5.39
  • MDXG 0.30
  • MACD
  • ROOT 1.55
  • MDXG -0.04
  • Stochastic Oscillator
  • ROOT 76.56
  • MDXG 51.24

About ROOT Root Inc.

Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. The company is a direct-to-consumer personal auto insurance, renters insurance and mobile technology company. It generates revenue from the sale of auto insurance policies within the United States.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: